Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

CKD-8 Data Details

Expand All

CKD-8 Reduce the number of new cases of end-stage renal disease (ESRD)

About the Data: National

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

Data Source: 
United States Renal Data System
Changed Since the Healthy People 2020 Launch: 
Yes
Measure: 
per 1,000,000 (age adjusted—see Comments)
Baseline (Year): 
391.2 (2007)
Target: 
352.0
Target-Setting Method: 
10 percent improvement
Numerator: 

Number of new patients requiring renal replacement therapy residing in U.S.

Denominator: 

Number of persons.

Comparable Healthy People 2010 Objective: 
Retained from HP2010 objective
Data Collection Frequency: 
Annual
Methodology Notes: 

    The end-stage renal disease (ESRD) population includes dialysis and kidney transplant recipients. Qualification for renal replacement therapy is based on the submission of the Centers for Medicare and Medicaid Services (CMS) Medical Evidence Form (CMS-2728).

    The United States Renal Disease System (USRDS) uses data collected by the CMS. Since 1996, Health Care providers have been required to provide patient information on all persons with ESRD, regardless of health insurance.

    Adjustment by age/gender/race: Age-specific rates are adjusted for gender and race/ethnicity. Gender-specific rates are adjusted for age and race/ethnicity. Race/ethnicity-specific rates are adjusted for age and gender.

    Age Adjustment Notes: 

    This Indicator uses Age-Adjustment Groups:

    • Total: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85+
    • Sex: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85+
    • Race/Ethnicity: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85+

About the Data: State

Description of the data source, numerator, denominator, survey questions, and other relevant details about the state-level data.

Data Source: 
United States Renal Data System
Measure: 
per 1,000,000 (age adjusted—see Comments) (age adjusted—see Comments)
Numerator: 

Number of new patients requiring renal replacement therapy residing in U.S.

Denominator: 

Number of persons.

Data Collection Frequency: 
Annual
Methodology Notes: 

      The end-stage renal disease (ESRD) population includes dialysis and kidney transplant recipients. Qualification for renal replacement therapy is based on the submission of the Centers for Medicare and Medicaid Services (CMS) Medical Evidence Form (CMS-2728).

      The United States Renal Disease System (USRDS) uses data collected by the CMS. Since 1996, Health Care providers have been required to provide patient information on all persons with ESRD, regardless of health insurance.

      Adjustment by age/gender/race: Age-specific rates are adjusted for gender and race/ethnicity. Gender-specific rates are adjusted for age and race/ethnicity. Race/ethnicity-specific rates are adjusted for age and gender.

    Age Adjustment Notes: 

    This Indicator uses Age-Adjustment Groups:

    • Total: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85+
    • Sex: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85+
    • Race/Ethnicity: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85+

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch: 
In 2018, the original baseline was revised from 353.8 to 391.1 per 1,000,000 due to USRDS rates re-estimation. There is some lag in reporting new cases of ESRD. Therefore, each year’s Annual Data Report includes re-estimates of earlier year rates. For more information see the USRDS Annual Data Reports. The target was adjusted from 318.5 to 352.0 per 1,000,000 to reflect the revised baseline using the original target-setting method.

References

Additional resources about the objective

  1. More information on the analytic methods used to calculate these rates can be found in Appendix A of the USRDS Annual Data Report Atlas.

  2. U.S. Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012